EPIC CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
| 2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
| 2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
| Sales 2008 | 22.12K 1.84M | Sales 2009 | 5.22K 435K | Capitalization | 563K 46.95M |
|---|---|---|---|---|---|
| Net income 2008 | - 0 | Net income 2009 | - 0 | EV / Sales 2008 | 33.3 x |
| Net Debt 2008 | 399K 33.31M | Net Debt 2009 | 673K 56.14M | EV / Sales 2009 | 237 x |
| P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | 2 |
| Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More news
1 year
0.00
0.00
3 years
0.000.41
5 years
0.000.70
10 years
0.004.89
| Managers | Title | Age | Since |
|---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 01/97/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 01/97/01 |
EPIC Corporation was engaged in developing and implementing the EPIC monetary system. Its EPIC monetary system included virtual money system called EPIC digital dollars. The Company has ceased all its business operations and has no plans to seek business opportunities.
Sector
Blockchain & Cryptocurrency
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 20 | |
| +35.88% | 58B | |
| +15.59% | 6.97B | |
| -11.18% | 864M | |
| -28.95% | 717M | |
| +126.67% | 614M | |
| +229.89% | 484M | |
| -52.94% | 328M | |
| -6.78% | 131M | |
| -.--% | 118M |
- Stock Market
- Equities
- EPOR Stock
